(2R)-2-acetamido-4-methylpentanoic acid | CAS:19764-30-8

We serve (2R)-2-acetamido-4-methylpentanoic acid CAS:19764-30-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
(2R)-2-acetamido-4-methylpentanoic acid

Chemical Name: (2R)-2-acetamido-4-methylpentanoic acid
CAS.NO: 19764-30-8
Molecular Formula:C8H15NO3
Molecular Weight:173.21000
 
Synonyms:
Ac-D-Leu-OH
D-leucine,N-acetyl
D-Leucine, N-acetyl-
N-Ac-D-leucine
2,N-Acetyl-D-leucine
N-Acetyl-D-leucine
(R)-N-acetyl-leucine
(R)-2-Acetamido-4-methylpentanoic acid
N-acetylleucin
N-Acetyl-D-leucin
(2R)-2-acetamido-4-methylpentanoic acid
N-Acethy-D-leucine
 
Physical and Chemical Properties:
Density: 1.069 g / cm3
Boiling point: 369.7ºC at 760 mmHg
Melting point: 176-177ºC
Flash point: 177.4ºC
Refractive index: 1.458
 
Specification:
Appearance: White to off-white powder
Purity:≥99%
Residue on ignition:≤0.3%
Loss on drying:≤0.5% 
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store at -20ºC.Keep the container tightly closed, put it in a tight dispenser, and store in a cool, dry place.
Application:Acetylleucine is a drug used in the treatment of vertigo.



Contact us for information like (2R)-2-acetamido-4-methylpentanoic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,N-Acethy-D-leucine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2,N-Acetyl-D-leucine Use and application,(R)-2-Acetamido-4-methylpentanoic acid technical grade,usp/ep/jp grade.


Related News: With the continuous accumulation of the API industry and the increasing maturity of the market, competition in China’s API industry will become increasingly fierce.N-[(S)-Ethoxycarbonyl-1-Butyl]-(S)-Alanine manufacturer Is there a cure? Not at the moment. Researchers have successfully grown the virus in a lab, an important step towards developing a vaccine — but it could be a year or more until it’s available.1-β-D-Arabinofuranosyluracil supplier In addition to APIs, a variety of pharmaceutical excipients are contained in the medicine.4-Bromomethyl-2-cyanobiphenyl vendor The oral form of rigosertib was developed to provide a potentially more convenient dosage form for use where the duration of treatment may extend to multiple years.The company’s pharmaceutical intermediate business is expected to maintain a growth rate of more than 30%.